{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T16:13:28Z","timestamp":1790266408050,"version":"4.1.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T00:00:00Z","timestamp":1776902400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009045","name":"Uniwersytet Jagiello\u0144ski Collegium Medicum","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009045","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015077","name":"Uniwersytet Jagiello\u0144ski Collegium Medicum","doi-asserted-by":"publisher","award":["N41\/DBS\/001328"],"award-info":[{"award-number":["N41\/DBS\/001328"]}],"id":[{"id":"10.13039\/100015077","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis Plus"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.athplu.2026.100564","type":"journal-article","created":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T03:47:17Z","timestamp":1777607237000},"page":"100564","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Associations of lipoprotein(a) concentrations with cardiovascular disease in men and women with primary hypercholesterolemia"],"prefix":"10.1016","volume":"65","author":[{"given":"Jakub","family":"Kurdziel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrzej","family":"Fedak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Micek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Przemys\u0142aw","family":"Miarka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maciej T.","family":"Ma\u0142ecki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6823-9577","authenticated-orcid":false,"given":"Ma\u0142gorzata","family":"Walu\u015b-Miarka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.athplu.2026.100564_bib1","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.jacc.2013.09.042","article-title":"Lipoprotein(a) for risk assessment in patients with established coronary artery disease","volume":"63","author":"O'Donoghue","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.athplu.2026.100564_bib2","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s10654-022-00956-4","article-title":"Circulating lipoprotein (a) and all-cause and cause-specific mortality: a systematic review and dose-response meta-analysis","volume":"38","author":"Amiri","year":"2023","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.athplu.2026.100564_bib3","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1093\/eurheartj\/ehx166","article-title":"Lipoprotein(a) and the risk of cardiovascular disease in the European population: results from the BiomarCaRE consortium","volume":"38","author":"Waldeyer","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.athplu.2026.100564_bib4","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.1161\/ATVBAHA.113.302479","article-title":"Plasma lipoprotein(a) concentration predicts future coronary and cardiovascular events in patients with stable coronary heart disease","volume":"33","author":"Nestel","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"9","key":"10.1016\/j.athplu.2026.100564_bib5","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.124.035353","article-title":"Sex differences in the association between lipoprotein(a) and cardiovascular outcomes: the MGB lp(a) registry","volume":"14","author":"Kaur","year":"2025","journal-title":"J Am Heart Assoc"},{"issue":"5","key":"10.1016\/j.athplu.2026.100564_bib6","doi-asserted-by":"crossref","first-page":"481","DOI":"10.33549\/physiolres.930511","article-title":"Gender differences in plasma levels of lipoprotein (a) in patients with angiographically proven coronary artery disease","volume":"53","author":"Frohlich","year":"2004","journal-title":"Physiol Res"},{"key":"10.1016\/j.athplu.2026.100564_bib7","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.atherosclerosis.2021.06.004","article-title":"Lipoprotein(a) levels and atherosclerotic plaque characteristics in the carotid artery: the plaque at RISK (PARISK) study","volume":"329","author":"van Dam-Nolen","year":"2021","journal-title":"Atherosclerosis"},{"issue":"12","key":"10.1016\/j.athplu.2026.100564_bib8","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.033654","article-title":"Genetics and pathophysiological mechanisms of Lipoprotein(a)-associated cardiovascular risk","volume":"13","author":"Volgman","year":"2024","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.athplu.2026.100564_bib9","series-title":"Non-genetic influences on lipoprotein(a) concentrations> atherosclerosis","first-page":"53","volume":"vol. 349","author":"Enkhama","year":"2022"},{"issue":"45","key":"10.1016\/j.athplu.2026.100564_bib10","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1093\/eurheartj\/eht273","article-title":"Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European atherosclerosis society","volume":"34","author":"Nordestgaard","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.athplu.2026.100564_bib11","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1016\/j.jacc.2020.03.065","article-title":"Ascertainment bias in the association between elevated lipoprotein(a) and familial hypercholesterolemia","volume":"75","author":"Trinder","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"21","key":"10.1016\/j.athplu.2026.100564_bib12","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1016\/j.jacc.2020.04.003","article-title":"Familial hypercholesterolemia and Lipoprotein(a): unraveling the knot that binds them","volume":"75","author":"Toth","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.athplu.2026.100564_bib13","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1016\/j.jacc.2014.01.063","article-title":"Lipoprotein(a) levels in familial hypercholesterolemia: an important predictor of cardiovascular disease independent of the type of LDL receptor mutation","volume":"63","author":"Alonso","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.athplu.2026.100564_bib14","series-title":"Clinical Guidelines and Evidence Review for Familial Hypercholesterolaemia: The Identification and Management of Adults and Children With Familial Hypercholesterolaemia","author":"DeMott","year":"2008"},{"key":"10.1016\/j.athplu.2026.100564_bib15","article-title":"Targeted sequencing of a gene Panel in patients with familial hypercholesterolemia from Southern Poland","volume":"133","author":"Toto\u0144\u2010\u017bura\u0144ska","year":"2023","journal-title":"Pol Arch Intern Med"},{"key":"10.1016\/j.athplu.2026.100564_bib16","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.metabol.2015.10.018","article-title":"The genetic spectrum of familial hypercholesterolemia in Southeastern Poland","volume":"65","author":"Sharifi","year":"2016","journal-title":"Metab, Clin Exp"},{"key":"10.1016\/j.athplu.2026.100564_bib17","doi-asserted-by":"crossref","first-page":"764","DOI":"10.3390\/jcm12030764","article-title":"Lipoprotein(a),Cardiovascular events and sex differences: a single cardiological unit experience","volume":"12","author":"Dal Pino","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.athplu.2026.100564_bib18","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.atherosclerosis.2022.06.1023","article-title":"Sex differences of lipoprotein(a) levels and associated risk of morbidity and mortality by age: the copenhagen general population study","volume":"355","author":"Simony","year":"2022","journal-title":"Atherosclerosis"},{"issue":"16","key":"10.1016\/j.athplu.2026.100564_bib19","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/j.jacc.2024.02.031","article-title":"Lipoprotein(a) and long-term cardiovascular risk in a multi-ethnic pooled prospective cohort","volume":"83","author":"Wong","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.athplu.2026.100564_bib20","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1161\/CIRCULATIONAHA.113.004406","article-title":"Lipoprotein(a) concentrations, rosuvastatin therapy, and residual vascular risk: an analysis from the JUPITER trial (Justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin)","volume":"129","author":"Khera","year":"2014","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.athplu.2026.100564_bib21","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1177\/00033197241239688","article-title":"Elevated plasma Lipoprotein(a) level and atherosclerotic cardiovascular disease risks: a large clinical retrospective study","volume":"76","author":"Wang","year":"2025","journal-title":"Angiology"},{"key":"10.1016\/j.athplu.2026.100564_bib22","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.jacc.2018.04.060","article-title":"Lipoprotein(a) and cardiovascular risk prediction among women","volume":"72","author":"Cook","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.athplu.2026.100564_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajpc.2025.101008","article-title":"The interactions of Lipoprotein(a) with common cardiovascular risk factors in cardiovascular disease risk: evidence based on the UK biobank","volume":"22","author":"Ao","year":"2025","journal-title":"Am J Prev Cardiol"},{"key":"10.1016\/j.athplu.2026.100564_bib24","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.atherosclerosis.2022.10.004","article-title":"Relationship of low-density lipoprotein-cholesterol and lipoprotein(a) to cardiovascular risk: the Multi-Ethnic Study of Atherosclerosis (MESA)","volume":"363","author":"Rikhi","year":"2022","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.athplu.2026.100564_bib25","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s11789-015-0074-0","article-title":"Lipoprotein(a) hyperlipidemia as cardiovascular risk factor: pathophysiological aspects","volume":"10","author":"Schmitz","year":"2015","journal-title":"Clin Res Cardiol Suppl"},{"issue":"14","key":"10.1016\/j.athplu.2026.100564_bib26","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/S0002-9149(96)00174-9","article-title":"Testosterone decreases lipoprotein(a) in men","volume":"77","author":"Zmunda","year":"1996","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.athplu.2026.100564_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajpc.2024.100885","article-title":"Lipoprotein(a) throughout life in women","volume":"20","author":"Corral","year":"2024","journal-title":"Am J Prev Cardiol"},{"issue":"2","key":"10.1016\/j.athplu.2026.100564_bib28","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jacc.2008.04.009","article-title":"Lipoprotein(a), hormone replacement therapy, and risk of future cardiovascular events","volume":"52","author":"Suk Danik","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.athplu.2026.100564_bib29","article-title":"Special aspects of cholesterol metabolism in women","volume":"14","author":"Gouni-Berthold","year":"2024","journal-title":"Dtsch Arztebl Int"},{"issue":"10459","key":"10.1016\/j.athplu.2026.100564_bib30","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/S0140-6736(24)01308-4","article-title":"Lipoprotein(a) and cardiovascular disease","volume":"404","author":"Nordestgaard","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.athplu.2026.100564_bib31","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1002\/clc.22500","article-title":"Lipoprotein (a) and increased cardiovascular risk in women","volume":"39","author":"Costello","year":"2016","journal-title":"Clin Cardiol"},{"issue":"5","key":"10.1016\/j.athplu.2026.100564_bib32","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1093\/eurjpc\/zwab052","article-title":"Lipoprotein (a) as a treatment target for cardiovascular disease prevention and related therapeutic strategies: a critical overview","volume":"29","author":"Parthymos","year":"2022","journal-title":"Eur J Prev Cardiol"},{"issue":"4","key":"10.1016\/j.athplu.2026.100564_bib33","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/HCO.0000000000001142","article-title":"From remnant cholesterol to lipoprotein(a) - emerging risk factors for cardiovascular diseases beyond low density lipoprotein","volume":"39","author":"Mukherjee","year":"2024","journal-title":"Curr Opin Cardiol"},{"issue":"39","key":"10.1016\/j.athplu.2026.100564_bib34","doi-asserted-by":"crossref","first-page":"4157","DOI":"10.1093\/eurheartj\/ehad472","article-title":"Cardiovascular disease: a call to action from the European atherosclerosis society","volume":"44","author":"Roeters van Lennep","year":"2023","journal-title":"Eur Heart J"}],"container-title":["Atherosclerosis Plus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667089526000180?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667089526000180?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T15:49:19Z","timestamp":1790264959000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667089526000180"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":34,"alternative-id":["S2667089526000180"],"URL":"https:\/\/doi.org\/10.1016\/j.athplu.2026.100564","relation":{},"ISSN":["2667-0895"],"issn-type":[{"value":"2667-0895","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Associations of lipoprotein(a) concentrations with cardiovascular disease in men and women with primary hypercholesterolemia","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis Plus","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.athplu.2026.100564","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100564"}}